Cargando…

PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA

Detalles Bibliográficos
Autores principales: Hajizadeh Barfejani, A., Prasad, S., Henry, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431490/
http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a
_version_ 1784780069641650176
author Hajizadeh Barfejani, A.
Prasad, S.
Henry, D.
author_facet Hajizadeh Barfejani, A.
Prasad, S.
Henry, D.
author_sort Hajizadeh Barfejani, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9431490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94314902022-08-31 PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA Hajizadeh Barfejani, A. Prasad, S. Henry, D. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431490/ http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Hajizadeh Barfejani, A.
Prasad, S.
Henry, D.
PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title_full PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title_fullStr PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title_full_unstemmed PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title_short PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
title_sort pb2324: safe administration of second dose of mrna covid-19 vaccine following development of idiopathic thrombocytopenic purpura
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431490/
http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a
work_keys_str_mv AT hajizadehbarfejania pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura
AT prasads pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura
AT henryd pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura